Tower Research Capital LLC (TRC) - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$11,068
-71.3%
6,549
-52.8%
0.00%
-100.0%
Q2 2023$38,556
+78585.7%
13,869
-48.7%
0.00%
-50.0%
Q1 2023$49
+48.5%
27,042
+326.8%
0.00%
+100.0%
Q4 2022$33
-99.9%
6,336
-1.7%
0.00%0.0%
Q3 2022$32,000
+45.5%
6,448
+11.6%
0.00%
Q2 2022$22,000
-89.9%
5,778
-85.1%
0.00%
-100.0%
Q1 2022$218,000
+37.1%
38,855
+48.4%
0.00%
-33.3%
Q4 2021$159,000
+37.1%
26,182
+119.6%
0.00%0.0%
Q3 2021$116,000
+11.5%
11,920
+64.0%
0.00%0.0%
Q2 2021$104,000
+166.7%
7,269
+343.5%
0.00%
+200.0%
Q1 2021$39,0001,6390.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders